Nature-Throid
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
14,801 recalls, newest first
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Reason Lack of CGMPs:
Reason Lack of CGMPs:
Reason Sub-Potent Drug: Out of specification test results for potency (below specification).
Reason CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
Reason CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
Reason Failed Dissolution Specifications
Reason CGMP Deviations
Reason CGMP Deviations
Reason GMP Deviations: Potential to contain 1-propanol.
Reason GMP Deviations: Potential to contain 1-propanol.
Reason cGMP Deviations
Reason cGMP Deviations
Reason Microbial Contamination of Non-Sterile Products: FDA laboratory analysis found product to be contaminated with various microorganisms including Enterobacter cloacae, Cronobacter sakazakii, Cronobacter dublinensis, among others.
Reason Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
Reason Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
Reason Marketed without an Approved NDA/ANDA; product labeled to contain 0.56% methanol making it an unapproved new drug
Reason Marketed without an Approved NDA/ANDA; product labeled to contain 0.56% methanol making it an unapproved new drug